Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2

  • Marta Terrile1, 2,
  • Irene Appolloni1, 2,
  • Filippo Calzolari1, 2,
  • Roberto Perris3, 4,
  • Evelina Tutucci1, 2, 5 and
  • Paolo Malatesta1, 2Email author
Contributed equally
BMC Cancer201010:550

DOI: 10.1186/1471-2407-10-550

Received: 13 April 2010

Accepted: 12 October 2010

Published: 12 October 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Apr 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
15 Jun 2010 Reviewed Reviewer Report - Oren Becher
29 Jun 2010 Reviewed Reviewer Report - Caroline Saucier
13 Aug 2010 Author responded Author comments - Paolo Malatesta
Resubmission - Version 3
13 Aug 2010 Submitted Manuscript version 3
3 Sep 2010 Reviewed Reviewer Report - Caroline Saucier
15 Sep 2010 Author responded Author comments - Paolo Malatesta
Resubmission - Version 4
15 Sep 2010 Submitted Manuscript version 4
8 Oct 2010 Author responded Author comments - Paolo Malatesta
Resubmission - Version 5
8 Oct 2010 Submitted Manuscript version 5
Publishing
12 Oct 2010 Editorially accepted
12 Oct 2010 Article published 10.1186/1471-2407-10-550

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
National Institute for Cancer Research (IST), IRCCS
(2)
Department of Oncology Biology and Genetics (DOBiG), University of Genoa
(3)
COMT - Centre for Molecular and Translational Oncology, University of Parma
(4)
Laboratory for Stem Cell Research and Cellular Therapy, Division for Experimental Oncology 2, The National Cancer Institute, Aviano, CRO-IRCCS
(5)
Department of Cell Biology, Sciences III

Advertisement